The new era in cancer treatment brings the experimental mRNA vaccine Intismeran, developed by Merck and Moderna, which offers the possibility of stopping the return of lethal melanoma with an individualized approach by teaching the body's immune system protective mechanisms. (translated)
The price of Moderna shares doubled after the publication of successful trial results for an mRNA-based cancer vaccine, which showed that it helps high-risk melanoma patients prevent cancer recurrence or spread. Both investors and scientists are critically awaiting these results, as they could open doors to a new treatment sector and improve Moderna's financial position. (translated)
Moderna's stock rose 105 percent after initial positive results from their and Merck's experimental melanoma vaccine, which customizes mRNA-based injections according to the patient's tumor, bringing hope. (translated)
Lapsepõlves saadud päikesepõletus suurendab melanoomi riski, mistõttu on oluline piirata otsese päikese käes viibimise aega ning kasutada kaitsekreeme, et vähendada naha kahjustuste ohtu ja hoolitseda noorte naharakkude eest. #päikesepõletus #melanoomi #uskumatudvalikud
